+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Coronavirus Test Kits Market by Product Type, Distribution Channel, End User, Sample Type, Application - Global Forecast to 2030- Product Image
Coronavirus Test Kits Market by Product Type, Distribution Channel, End User, Sample Type, Application - Global Forecast to 2030- Product Image
Sale

Coronavirus Test Kits Market by Product Type, Distribution Channel, End User, Sample Type, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674762
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Coronavirus Test Kits Market grew from USD 22.24 billion in 2024 to USD 25.55 billion in 2025. It is expected to continue growing at a CAGR of 14.47%, reaching USD 50.04 billion by 2030.

Setting the Stage for Comprehensive Coronavirus Testing Strategies

In recent years, the global urgency to detect and contain coronavirus has propelled diagnostic test kits to the forefront of public health strategy. From early antibody assays to advanced molecular diagnostics, test kit innovation has been pivotal in shaping epidemiological responses and enabling more targeted interventions. Beyond the acute phase of the pandemic, enduring demand for reliable, rapid, and scalable testing solutions continues to influence procurement policies and research agendas worldwide.

This executive summary distills critical learnings from multiple perspectives, including evolving technology platforms, regulatory trajectories, and emerging market complexities. By grounding the analysis in empirical data and expert insights, decision-makers will gain clarity on the factors that have driven supply chain realignments, pricing dynamics, and adoption trends across different healthcare settings. The narrative that follows offers a structured, yet deep, exploration of how the coronavirus test kit landscape has transformed and where future opportunities lie.

Revolutionary Transformations Redefining the Coronavirus Test Kit Market

The coronavirus test kit market has undergone a profound metamorphosis as scientific breakthroughs, digital integration, and shifting regulatory priorities converge. Innovations in isothermal nucleic acid amplification have reduced turnaround times while maintaining high analytical sensitivity. Simultaneously, the proliferation of lateral flow immunoassays and fluorescent immunoassays has democratized access to point-of-care screening, enabling clinicians and consumers alike to obtain results without centralized laboratory infrastructure.

Regulatory frameworks have also adapted in tandem, introducing expedited review pathways and real-world performance evaluations that balance speed with reliability. Public-private collaborations have become instrumental in accelerating scale-up, exemplified by alliances between diagnostic developers and contract manufacturers. Emerging integration of data management platforms has further enhanced traceability and epidemiological surveillance, underscoring a shift toward more holistic, digitally enabled testing ecosystems.

Assessing the 2025 US Tariff Influence on Test Kit Economics

The imposition of heightened United States tariffs in 2025 introduced new cost pressures across the coronavirus test kit value chain, compelling manufacturers and distributors to reassess sourcing strategies. Components such as reagents, specialized plastics, and detection antibodies experienced incremental price increases, which in turn affected per-test economics and reimbursement negotiations.

In response, several stakeholders have repatriated key manufacturing steps to mitigate tariff exposure, although this transition demands substantial capital investment and workforce training. Others have pursued alternative low-tariff jurisdictions and free trade agreements to sustain competitiveness, leading to a more geographically diversified supply network. Collectively, these adaptations signal a strategic recalibration that prioritizes supply chain resilience and cost optimization, while ensuring test availability remains uninterrupted in high-demand regions.

Unpacking Core Segmentation Drivers for Diverse Testing Demands

An in-depth view of product portfolio dynamics reveals that antibody detection methods, spanning chemiluminescence immunoassay and enzyme-linked immunosorbent assay platforms, cater predominantly to post-infection surveillance and seroprevalence studies. In contrast, polymerase chain reaction modalities-encompassing both isothermal amplification and real-time PCR technologies-continue to serve as the diagnostic gold standard in clinical laboratories. Rapid antigen testing, leveraging fluorescent immunoassay and lateral flow immunoassay formats, has secured a prominent role in decentralized screening protocols, particularly where turnaround time and ease of use take precedence over analytical sensitivity.

Distribution channel analysis highlights a distinct bifurcation: diagnostic laboratories focus on high-throughput PCR and ELISA workflows, while hospital pharmacies integrate rapid immunoassay kits into point-of-care instruments. Concurrently, online pharmacies have emerged as key enablers of home testing solutions, and traditional retail pharmacies are expanding their footprint by offering both professional and self-collection kits. End users exhibit similarly diverse preferences; diagnostic centers emphasize accuracy and batch processing, home care settings demand user-friendly formats and clear instructions, and hospitals require scalable inventory to support routine and outbreak responses.

Sample type considerations also drive product design and adoption. Blood sampling remains central to serological studies, while nasopharyngeal and oropharyngeal swabs maintain primacy for molecular detection. Saliva-based collection is gaining traction due to its noninvasive nature and compatibility with high-volume screening. Finally, application domains diverge between clinical diagnosis, home testing, and research use cases, each imposing distinct requirements on sensitivity, regulatory labeling, and data integration.

Regional Dynamics Shaping Global Test Kit Trajectories

Regional market characteristics underscore how localized policies, infrastructure maturity, and pandemic trajectories shape demand patterns. In the Americas, centralized manufacturing hubs and robust reimbursement frameworks have accelerated adoption of high-sensitivity PCR assays, while point-of-care antigen kits have been deployed extensively in community testing initiatives. North American laboratories benefit from streamlined regulatory clearances, fostering rapid commercialization of cutting-edge platforms.

Across Europe, Middle East & Africa, variation in regulatory harmonization and healthcare funding models has created a mosaic of market entry strategies. Some countries leverage coordinated procurement consortia to secure volume discounts, whereas others prioritize domestic production to reduce reliance on imports. Investment in mobile diagnostic units and cross-border data sharing agreements has enhanced testing reach in resource-constrained areas, demonstrating a flexible approach to public health management.

Asia-Pacific exhibits one of the fastest growth trajectories, driven by proactive government mandates and large-scale national testing campaigns. Local manufacturers have scaled up output through technology licensing and public sector partnerships, underpinning cost-effective solutions tailored to diverse population densities. The integration of digital health credentials and mobile reporting has further optimized testing workflows, reflecting a convergence of biotech innovation and digital transformation.

Strategic Moves from Industry-Leading Diagnostic Innovators

Leading diagnostic innovators continue to shape industry direction through strategic R&D investments and capacity expansion. One multinational firm has broadened its portfolio with next-generation PCR instruments that integrate automated sample handling, reducing labor requirements and error rates. Another global player has prioritized modular assay design, enabling rapid reconfiguration to detect emerging variants and other respiratory pathogens.

Partnerships between testing developers and technology providers have produced hybrid solutions that combine assay kits with digital result tracking, fueling wider acceptance among institutional buyers. Meanwhile, smaller niche companies differentiate through specialized reagents and reagent-less sensor technologies that offer ultra-rapid turnaround. Across the competitive landscape, mergers and acquisitions remain prevalent as companies seek to consolidate market share, expand geographic reach, and integrate complementary capabilities within end-to-end diagnostic ecosystems.

Strategic Imperatives to Navigate Growth and Risk

To navigate evolving market complexities, industry leaders should prioritize diversification of their supply networks by establishing dual-sourcing agreements and regional manufacturing capacities. Investing in automated production lines not only enhances throughput but also reduces dependency on skilled labor, thus mitigating operational risk. Strengthening regulatory engagement through continuous dialogue with health authorities will facilitate faster approvals for novel platforms, while collaborative validation studies can streamline market access.

Expanding digital health integrations-such as cloud-based reporting and mobile result notifications-can differentiate product offerings and improve end-user adherence. Companies should also monitor emerging segments, including at-home surveillance and multiplex respiratory panels, to capture new revenue streams. Finally, dynamic pricing strategies aligned to regional purchasing power and reimbursement structures will ensure both accessibility and margin protection, positioning organizations for sustainable growth in a competitive environment.

Rigorous Research Approach Underpinning Market Intelligence

This analysis draws on a comprehensive blend of primary and secondary research methodologies. Primary insights were gathered through structured interviews with senior stakeholders in diagnostic manufacturing, distribution, and healthcare delivery. Secondary data sources include peer-reviewed publications, regulatory filings, patent landscapes, and authoritative industry databases. Data triangulation techniques were employed to reconcile discrepancies and validate key findings.

Quantitative analyses focused on supply chain mapping, cost drivers, and adoption curves, while qualitative syntheses assessed technological readiness levels, regulatory evolutions, and competitive positioning. The research process was subject to rigorous quality assurance protocols, including multi-tiered peer reviews and iterative validation rounds with domain experts. This robust approach ensures that strategic insights rest on a foundation of transparency, reliability, and real-world applicability.

Synthesis of Key Findings and Future Outlook

The coronavirus test kit market stands at an inflection point defined by rapid technological advancement, shifting trade policies, and evolving stakeholder expectations. Analysis of segmentation dynamics reveals enduring opportunities across product types, distribution channels, end users, sample modalities, and application domains. Regional examinations highlight how localized strategies and infrastructure capabilities inform demand patterns and competitive responses.

Companies that adapt through strategic supply chain diversification, regulatory engagement, and digital integration will be best positioned to thrive in a marketplace that values speed, accuracy, and affordability. Continuous monitoring of tariff landscapes and technological breakthroughs will remain critical as the industry transitions from pandemic-driven urgency to long-term public health integration. Armed with these insights, decision-makers can chart a roadmap that balances resilience with innovation, ensuring readiness for both present challenges and future health scenarios.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Antibody
      • Chemiluminescence Immunoassay
      • Enzyme-Linked Immunosorbent Assay
    • Polymerase Chain Reaction
      • Isothermal Amplification
      • Real-Time PCR
    • Rapid Antigen
      • Fluorescent Immunoassay
      • Lateral Flow Immunoassay
  • Distribution Channel
    • Diagnostic Laboratories
    • Hospital Pharmacy
    • Online Pharmacies
    • Retail Pharmacies
  • End User
    • Diagnostic Centers
    • Home Care Settings
    • Hospitals
  • Sample Type
    • Blood
    • Nasopharyngeal Swabs
    • Oropharyngeal Swabs
    • Saliva
  • Application
    • Clinical Diagnosis
    • Home Testing
    • Research
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Siemens Healthineers AG
  • Qiagen N.V.
  • Bio-Rad Laboratories, Inc.
  • Hologic, Inc.
  • bioMérieux SA
  • PerkinElmer, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Coronavirus Test Kits Market, by Product Type
8.1. Introduction
8.2. Antibody
8.2.1. Chemiluminescence Immunoassay
8.2.2. Enzyme-Linked Immunosorbent Assay
8.3. Polymerase Chain Reaction
8.3.1. Isothermal Amplification
8.3.2. Real-Time PCR
8.4. Rapid Antigen
8.4.1. Fluorescent Immunoassay
8.4.2. Lateral Flow Immunoassay
9. Coronavirus Test Kits Market, by Distribution Channel
9.1. Introduction
9.2. Diagnostic Laboratories
9.3. Hospital Pharmacy
9.4. Online Pharmacies
9.5. Retail Pharmacies
10. Coronavirus Test Kits Market, by End User
10.1. Introduction
10.2. Diagnostic Centers
10.3. Home Care Settings
10.4. Hospitals
11. Coronavirus Test Kits Market, by Sample Type
11.1. Introduction
11.2. Blood
11.3. Nasopharyngeal Swabs
11.4. Oropharyngeal Swabs
11.5. Saliva
12. Coronavirus Test Kits Market, by Application
12.1. Introduction
12.2. Clinical Diagnosis
12.3. Home Testing
12.4. Research
13. Americas Coronavirus Test Kits Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Coronavirus Test Kits Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Coronavirus Test Kits Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. F. Hoffmann-La Roche Ltd
16.3.3. Thermo Fisher Scientific Inc.
16.3.4. Danaher Corporation
16.3.5. Siemens Healthineers AG
16.3.6. Qiagen N.V.
16.3.7. Bio-Rad Laboratories, Inc.
16.3.8. Hologic, Inc.
16.3.9. bioMérieux SA
16.3.10. PerkinElmer, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CORONAVIRUS TEST KITS MARKET MULTI-CURRENCY
FIGURE 2. CORONAVIRUS TEST KITS MARKET MULTI-LANGUAGE
FIGURE 3. CORONAVIRUS TEST KITS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CORONAVIRUS TEST KITS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CORONAVIRUS TEST KITS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CORONAVIRUS TEST KITS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CORONAVIRUS TEST KITS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CORONAVIRUS TEST KITS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY FLUORESCENT IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY NASOPHARYNGEAL SWABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY OROPHARYNGEAL SWABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY HOME TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CORONAVIRUS TEST KITS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 55. CANADA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. CANADA CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 57. CANADA CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 58. CANADA CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 59. CANADA CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. CANADA CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. CANADA CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 62. CANADA CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. MEXICO CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 65. MEXICO CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 66. MEXICO CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 67. MEXICO CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. MEXICO CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. MEXICO CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 70. MEXICO CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. GERMANY CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. GERMANY CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 106. GERMANY CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 107. GERMANY CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 108. GERMANY CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. GERMANY CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. GERMANY CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 111. GERMANY CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. FRANCE CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. FRANCE CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 114. FRANCE CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 115. FRANCE CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 116. FRANCE CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. FRANCE CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. FRANCE CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 119. FRANCE CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. ITALY CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. ITALY CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 130. ITALY CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 131. ITALY CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 132. ITALY CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. ITALY CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. ITALY CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 135. ITALY CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. SPAIN CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. SPAIN CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 138. SPAIN CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 139. SPAIN CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 140. SPAIN CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. SPAIN CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. SPAIN CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 143. SPAIN CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. DENMARK CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. DENMARK CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 170. DENMARK CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 171. DENMARK CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 172. DENMARK CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. DENMARK CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. DENMARK CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 175. DENMARK CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. QATAR CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. QATAR CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 186. QATAR CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 187. QATAR CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 188. QATAR CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. QATAR CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. QATAR CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 191. QATAR CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. FINLAND CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. FINLAND CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 194. FINLAND CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 195. FINLAND CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 196. FINLAND CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. FINLAND CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. FINLAND CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 199. FINLAND CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. EGYPT CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. EGYPT CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 218. EGYPT CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 219. EGYPT CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 220. EGYPT CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. EGYPT CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. EGYPT CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 223. EGYPT CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. TURKEY CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. TURKEY CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 226. TURKEY CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 227. TURKEY CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 228. TURKEY CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. TURKEY CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. TURKEY CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 231. TURKEY CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. NORWAY CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 241. NORWAY CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 242. NORWAY CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 243. NORWAY CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 244. NORWAY CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. NORWAY CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. NORWAY CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 247. NORWAY CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. POLAND CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. POLAND CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 250. POLAND CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 251. POLAND CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 252. POLAND CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. POLAND CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. POLAND CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 255. POLAND CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 273. CHINA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. CHINA CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 275. CHINA CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 276. CHINA CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 277. CHINA CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. CHINA CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. CHINA CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 280. CHINA CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. INDIA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 282. INDIA CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 283. INDIA CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 284. INDIA CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 285. INDIA CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. INDIA CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. INDIA CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 288. INDIA CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. JAPAN CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 290. JAPAN CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 291. JAPAN CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 292. JAPAN CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 293. JAPAN CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 294. JAPAN CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. JAPAN CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 296. JAPAN CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 321. THAILAND CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 322. THAILAND CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 323. THAILAND CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 324. THAILAND CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 325. THAILAND CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 326. THAILAND CORONAVIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 327. THAILAND CORONAVIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 328. THAILAND CORONAVIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES CORONAVIRUS TEST KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES CORONAVIRUS TEST KITS MARKET SIZE, BY RAPID ANTIGEN, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES CORONAVIRUS TEST KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES CORONAVIRUS T

Companies Mentioned

The companies profiled in this Coronavirus Test Kits market report include:
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Siemens Healthineers AG
  • Qiagen N.V.
  • Bio-Rad Laboratories, Inc.
  • Hologic, Inc.
  • bioMérieux SA
  • PerkinElmer, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 25.55 Billion
Forecasted Market Value ( USD ) by 2030 $ 50.04 Billion
Compound Annual Growth Rate14.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Coronavirus Test Kits Market 2024-2028 - Product Image

Coronavirus Test Kits Market 2024-2028

  • Report
  • 172 Pages
  • Global
From
COVID-19 Detection Kits Market Size, Share & Trends Analysis Report By Product (RT-PCR Assay Kits), By Sample Type (Nasopharyngeal), By Mode (Centralized Testing), By End-use (Laboratories), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

COVID-19 Detection Kits Market Size, Share & Trends Analysis Report By Product (RT-PCR Assay Kits), By Sample Type (Nasopharyngeal), By Mode (Centralized Testing), By End-use (Laboratories), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 110 Pages
  • Global
From
2024-2028 Global Coronavirus Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation - Product Image

2024-2028 Global Coronavirus Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • Report
  • Global
From
Coronavirus Test Kits Market in North America 2024-2028 - Product Image

Coronavirus Test Kits Market in North America 2024-2028

  • Report
  • 158 Pages
  • North America
From
Global COVID Rapid Diagnostic Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global COVID Rapid Diagnostic Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 120 Pages
  • Global
From

About the POC COVID Diagnostics Market

The POC COVID Diagnostics market is a subset of the Diagnostics industry, focused on the development and production of point-of-care (POC) tests for the detection of the novel coronavirus. These tests are designed to provide rapid results, allowing for quick diagnosis and treatment of patients. POC COVID Diagnostics tests are typically conducted using a variety of methods, such as antigen tests, antibody tests, and molecular tests. The POC COVID Diagnostics market has seen a surge in demand due to the pandemic, with many companies investing in the development of new tests and technologies. This has led to an increase in the number of companies offering POC COVID Diagnostics tests, as well as an increase in the number of tests available. Some of the companies in the POC COVID Diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Roche Diagnostics, and Quidel Corporation. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.